Shile Huang
Molecular Medicine · 2011
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Medicine — 12 citations into it
Whom Shile Huang trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Bharat B. Aggarwal (in Molecular Medicine)
Papers from Shile Huang's perspective
Ordered by how strongly the researchers Shile Huang trusts endorse each paper. Same corpus, a different order for every researcher.
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
- Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
- mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* (Journal of Biological Chemistry)
- GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. (Molecules and Cells)
- Cyclooxygenase 2: a molecular target for cancer prevention and treatment. (TIPS - Trends in Pharmacological Sciences)
- Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. (Anticancer Research)
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive (Nature Cell Biology)
- Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of…
- Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear… (Cancer Research)
Their papers
- Targets of curcumin (2011) — 745 citations